|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 最新AD研究用诊断标准:IWG-2标准显示文摘在过去的8年中,国际工作组织(IWG)和美国国立老化研究院-阿尔茨海默协会(NIA-AA)建立了阿尔茨海默病(AD)诊断标准,它能更好地定义AD的临床表型,整合了生物标记物于诊断流程中,并覆盖了疾病的全程。本意见书充分地权衡了IWG标准的优缺点,建议改进诊断框架。依据这些改进,AD的诊断变得简单,只要有恰当的AD临床表型(典型或不典型)和与AD的病理相一致的病理生理学生物标志物出现。我们认为疾病的下游的定位性生物标志,如容积性磁共振成像(MRI)和氟脱氧葡萄糖-正电子发射型计算机断层成像(FDG-PET)等,适合更好地测量和监测疾病过程。本文还详述了非典型性AD、混合性AD和AD临床前期的特异诊断标准。 | 陈刚 曹雯炜 俞羚 糜建华 Dubois B Feldman HH Jacova C Hampel H Molinuevo JL Blennow K DeK osky ST Gauthier S Selkoe D Bateman R Cappa S Crutch S Engelborghs S Frisoni GB Fox NC Galasko D Habert MO Jicha GA Nordberg A Pasquier F Rabinovici G Robert P Rowe C Salloway S Sarazin M Epelbaum S de Souza LC Vellas B Visser PJ Schneider L Stern Y Scheltens P Cummings JL | 2014 | 神经病学与神经康复学杂志2014，11，3： | 31 |
| 2 | Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: An association study in New Zealand Caucasians and meta-analysis显示文摘AIM:To investigate the association of macrophage migration inhibitory factor(MIF)promoter polymorphisms with inflammatory bowel disease(IBD)risk.METHODS:One thousand and six New Zealand Caucasian cases and 540 Caucasian controls were genotyped for the MIF SNP-173G>C(rs755622)and the repeat polymorphism CATT5-8(rs5844572)using a predesigned TaqMan SNP assay and capillary electrophoresis,respectively.Data were analysed for single site and haplotype association with IBD risk and phenotype.Meta-analysis was employed,to assess cumulative evidence of association of MIF-173G>C with IBD.All published genotype data for MIF-173G>C in IBD were identified using PubMed and subsequently searching the references of all PubMed-identified studies.Imputed genotypes for MIF-173G>C were generated from the Wellcome Trust Case Control Consortium(and National Institute of Diabetes and Digestive and Kidney Diseases).Separate meta-analyses were performed on Caucasian Crohn’s disease(CD)(3863 patients,6031controls),Caucasian ulcerative colitis(UC)(1260 patients,1987 controls),and East Asian UC(416 patients and 789 controls)datasets using the Mantel-Haenszel method.The New Zealand dataset had 93%power,and the meta-analyses had 100%power to detect an effect size of OR=1.40 atα=0.05,respectively.RESULTS:In our New Zealand dataset,single-site analysis found no evidence of association of MIF polymorphisms with overall risk of CD,UC,and IBD or disease phenotype(all P values>0.05).Haplotype analysis found the CATT5/-173C haplotype occurred at a higher frequency in New Zealand controls compared to IBD patients(0.6 vs 0.01;P=0.03,OR=0.22;95%CI:0.05-0.99),but this association did not survive bonferroni correction.Meta-analysis of our New Zealand MIF-173G>C data with data from seven additional Caucasian datasets using a random effects model found no association of MIF polymorphisms with CD,UC,or overall IBD.Similarly,meta-analysis of all published MIF-173G>C data from East Asian datasets(416UC patients,789 controls)found no association of this promoter polymorphism with UC. | James D Falvey Robert W Bentley Tony R Merriman Mark B Hampton Murray L Barclay Richard B Gearry Rebecca L Roberts | 2013 | World Journal of Gastroenterology2013，19，39： | 9 |
| 3 | Recent trends in liver transplantation for alcoholic liver disease in the United States显示文摘AIM To examine temporal changes in the indications for liver transplantation(LT) and characteristics of patients transplanted for alcoholic liver disease(ALD).METHODS We performed a retrospective cohort analysis of trends in the indication for LT using the United Network for Organ Sharing(UNOS) database between 2002 and 2015. Patients were grouped by etiology of the liver disease and characteristics were compared using χ~2 and t-tests. Time series analysis was used identifying any year with a significant change in the number of transplants per year for ALD, and before and after eras were modeled using a general linear model. Subgroup analysis of recipients with ALD was performed by age group, gender, UNOS region and etiology(alcoholic cirrhosis, alcoholic hepatitis and hepatitis C-alcoholic cirrhosis dual listing).RESULTS Of 74216 liver transplant recipients, ALD(n = 9400, 12.7%) was the third leading indication for transplant after hepatitis C and hepatocellular carcinoma. Transplants for ALD, increased from 12.8%(553) in 2002 to 16.5%(1020) in 2015. Time series analysis indicated a significant increase in the number of transplants per year for ALD in 2013(P = 0.03). There were a stable number of transplants per year between 2002 and 2012(linear coefficient 3, 95%CI:-4.6, 11.2) an increase of 177 per year between 2013 and 2015(95%CI: 119, 234). This increase was significant for all age groups except those 71-83 years old, was observed for both genders, and was incompletely explained by a decrease in transplants for hepatitis C and ALD dual listing. All UNOS regions except region 9 saw an increase in the mean number of transplants per year when comparing eras, and this increase was significant in regions 2, 3, 4, 5, 6, 8, 10 and 11.CONCLUSION There has been a dramatic increase in the number of transplants for ALD starting in 2013. | Catherine E Kling James D Perkins Robert L Carithers Dennis M Donovan Lena Sibulesky | 2017 | World Journal of Hepatology2017，9，36： | 6 |
| 4 | 中国极化电子离子对撞机计划显示文摘轻子散射实验是探索核子与原子核结构的理想工具。中国电子离子对撞机(Electron Ion Collider in China,EicC)建议书设想在已开建的强流重离子加速器装置(High Intensity heavy ion Accelerator Facility,HIAF)的基础上,升级质子束流为20 GeV的极化束流,并建造2.8~5 GeV极化电子束流,从而实现质心系能量为15~20 GeV的双极化电子-离子对撞。EicC设计的亮度为(2~4)×10^33cm^-2·s^-1,质子束流极化率达到70%,电子束流极化率达到80%。该装置除了能提供极化轻离子束流(例如:氦-3)外,也可产生非极化重离子束流(碳-12~铀-238)。EicC将聚焦核子海夸克部分子结构、原子核物质结构与性质、奇特强子态三个方面的物理研究。高亮度、高精度的对撞机有助于精确地测量核子结构函数并对核子进行三维成像,揭示强相互作用的动力学规律;原子核部分子分布包括核子短程关联以及原子核介质效应同样是该提案的重要科学目标;EicC能区接近重味夸克产生阈值,在研究重味强子谱方面拥有低背景的独特优势,有助于发现研究新的奇特强子态。质子质量起源问题也可以通过重味矢量介子的产生来研究。为了完成上述物理目标,我们将利用最先进的探测器技术建造接近全立体角覆盖的EicC对撞机谱仪。在准备EicC白皮书的过程中,我们得到世界各国专家的支持。EicC的物理与已有的实验和美国即将建设的EIC中的物理项目相互补充。EicC的建成及运行有望引领前沿的中高能核物理研究,使我国在加速器和探测器先进技术等领域实现跨越式发展,为我国核物理与强子物理以及相关科学领域提供大型综合实验平台与人才培养基地。 | 曹须 常雷 畅宁波 陈旭荣 陈卓俊 崔著钫 戴凌云 邓维天 丁明慧 龚畅 桂龙成 郭奉坤 韩成栋 何军 黄虹霞 黄银 Kaptari L P 李德民 李衡讷 李民祥 李学潜 梁羽铁 梁作堂 刘国明 刘杰 刘柳明 刘翔 罗晓峰 吕准 马伯强 马伏 马建平 马余刚 冒立军 Mezrag C 平加伦 秦思学 任航 Roberts C D 申国栋 史潮 宋勤涛 孙昊 王恩科 王凡 王倩 王荣 王睿儒 王涛峰 王伟 王晓玉 王晓云 吴佳俊 吴兴刚 肖博文 肖国青 谢聚军 谢亚平 邢宏喜 徐瑚珊 许怒 徐书生 鄢文标 闫文成 闫新虎 杨建成 杨一玻 杨智 姚德良 尹佩林 詹文龙 张建辉 张金龙 张鹏鸣 张肇西 张振宇 赵红卫 赵光达 赵强 赵宇翔 赵政国 郑亮 周剑 周详 周小蓉 邹冰松 邹丽平 | 2020 | 核技术2020，43，2： | 3 |
| 5 | Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians显示文摘 | Getchell Jane P Wroblewski Kelly E DeMaria Alfred Bean Christine L Parker Monica M Pandori Mark Dufour D Robert Busch Michael P Brecher Mark E Meyer William A Pesano Rick L Teo Chong-Gee Beckett Geoffrey A Araujo Aufra C Branson Bernard M D | 2013 | MMWR. Morbidity and Mortality Weekly Report2013，，18： | 3 |
| 6 | A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine显示文摘 | Marc Lémann Jean-Yves Mary Jean-Frédéric Colombel Bernard Duclos Jean-Claude Soule Eric Lerebours Robert Modigliani Yoram Bouhnik | 2005 | Gastroenterology2005，，7： | 2 |
| 7 | 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial显示文摘 | E Robert Greenberg Garnet L Anderson Douglas R Morgan Javier Torres William D Chey Luis Eduardo Bravo Ricardo L Dominguez Catterina Ferreccio Rolando Herrero Eduardo C Lazcano-Ponce María Mercedes Meza-Montenegro Rodolfo Pe?a Edgar M Pe?a Eduardo Salazar- | 2011 | The Lancet2011，，9790： | 2 |
| 8 | Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy显示文摘 | Sinha Rohit Anthony You Seo-Hee Zhou Jin Siddique Mobin M Bay Boon-Huat Zhu Xuguang Privalsky Martin L Cheng Sheue-Yann Stevens Robert D Summers Scott A Newgard Christopher B Lazar Mitchell A Yen Paul M | 2012 | EN2012，，7： | 2 |
| 9 | Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett’s oesophagus: a prospective study显示文摘 | Thomas L Vaughan Linda M Dong Patricia L Blount Kamran Ayub Robert D Odze Carissa A Sanchez Peter S Rabinovitch Brian J Reid | 2005 | Lancet Oncology2005，，12： | 2 |
| 10 | Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections显示文摘 | York E Miller Lori D Dwyer-Nield Robert L Keith Mysan Le Wilbur A Franklin Alvin M Malkinson | 2003 | Cancer Letters2003，，2： | 2 |
| 11 | D-MELD risk capping improves post-transplant and overall mortality under markov microsimulation显示文摘AIM: To hypothesize that the product of calculated Model for End-Stage Liver Disease score excluding exception points and donor age(D-MELD) risk capping ± Rule 14 could improve post liver transplant and overall survival after listing.METHODS: Probabilities derived from the United Network for Organ Sharing database between 2002 and 2004 were used to simulate potential outcomes for all patients listed for transplantation. The Markov simula-tion was then modified by screening matches using a 1200 or 1600 D-MELD risk cap ± allowing transplants for Model for End-Stage Liver Disease(MELD) ≤ 14(Rule 14). The differential impact of the rule changes was assessed.RESULTS: The Markov simulation accurately reproduced overall and post transplant survival. A 1200 D-MELD risk cap improved post-transplant survival. Both the 1200 and 1600 risk caps improved overall survival for waitlisted patients. The addition of Rule 14 further improved post transplant and overall survival by redistribution of donor livers to recipients in higher MELD subgroups. The mechanism for improved overall and post-transplant survival after listing was due to shifting a larger percentage of transplants to the moderate MELD score subgroup(MELD 15-29) while also ensuring that high MELD recipients have livers of high quality to achieve excellent post transplant survival.CONCLUSION: A 1200 D-MELD risk cap + Rule 14 provided the greatest overall benefit primarily by focusing liver transplantation towards the moderate MELD recipient. | Jeffrey B Halldorson Robert L Carithers Jr Renuka Bhattacharya Ramasamy Bakthavatsalam Iris W Liou Andre A Dick Jorge D Reyes James D Perkins | 2014 | World Journal of Transplantation2014，4，3： | 2 |
| 12 | Application of Burkholderia cepacia and Trichoderma virens,alone and in combinations,a-gainst Meloidogyne incognita on bell pepper显示文摘 | MEYER S L F ROBERTS D P CHITWOOD D J | 2001 | Nematropica2001，，： | 1 |
| 13 | Quantiy aboveground biomass and estimating net aboveground primary production for wetland macrophytes using a non- destructive phenometric technique显示文摘 | Robert J D Daniel L C | 1998 | Aquactic Botany1998，62，： | 1 |
| 14 | Electrochemical generation of aluminum sorbent for fluoride adsorption显示文摘 | Chen L Y Robert D | 2002 | Journal of Hazardous Mate- rials2002，94，3： | 1 |
| 15 | Modification of geometric model through variational geometry显示文摘 | ROBERT L DAVID G D C | 1982 | CAD1982，14，4： | 1 |
| 16 | Cyclietest of four-story steel plate sheawall显示文摘 | Driver Robert G Kulak Geoffrey L Kenned D J Laurie | 1998 | Journal of Structural Engineering1998，124，2： | 1 |
| 17 | Changes in stoichiometric Si, N and P ratios of Mississippi River water diverted through coastal wetlands to the Gulf of Mexico 显示文摘 | Robert R L John W D Dubravko J | 2004 | Estuarine Coastal and Shelf Science2004，60，1： | 1 |
| 18 | Last interglacial age for aeolian and ma- rine deposits and the Nahoon fossil human footprints, South- east Coast of South Africa 显示文摘 | Jacobs Z Roberts D L | 2009 | Quaternary Geochronology2009，4，2： | 1 |
| 19 | The Effect of a Translucent Post on Resin Composite:Depth of Cure显示文摘 | Roberts H W Leonard D L Vandew alle K S | | 0，，07： | 1 |
| 20 | Bacterial RNA chaperones confer abiotic stress tolerance in plants and improved grain yield in maize under water-limited condition 显示文摘 | Paolo C Dave W Robert J B Don C A Jay H Martin S Mark A Ganesh K Sara S Robert D Santiago N Stephanie B Mary F Jayaprakash T Santanu D Christopher B Michael H L Jacqueline E H | 2008 | Plant Physiology2008，147，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员